Rhythm Pharmaceuticals Inc Earnings

Rhythm Pharmaceuticals Inc’s revenue jumped 66.8% since last year same period to $48.5Mn in the Q2 2025. On a quarterly growth basis, Rhythm Pharmaceuticals Inc has generated 48.31% jump in its revenue since last 3-months.

Rhythm Pharmaceuticals Inc’s net profit fell -44.55% since last year same period to $-46.63Mn in the Q2 2025. On a quarterly growth basis, Rhythm Pharmaceuticals Inc has generated 5.79% jump in its net profits since last 3-months.

Rhythm Pharmaceuticals Inc’s net profit margin jumped 13.34% since last year same period to -96.14% in the Q2 2025. On a quarterly growth basis, Rhythm Pharmaceuticals Inc has generated 36.48% jump in its net profit margins since last 3-months.

Rhythm Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at -0.69 - a -2.6% fall from last quarter’s estimates.

Rhythm Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at -0.69.

Rhythm Pharmaceuticals Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Rhythm Pharmaceuticals Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.